Comparative in-vitro activity of SCH 27899, a novel everninomicin, and vancomycin.

Comparative in-vitro activity of SCH 27899, a novel everninomicin, and vancomycin.

Item
http://www.wikidata.org/entity/Q39425509
Pharmacologic and bacteriologic properties of SCH-27899 (Ziracin), an investigational antibiotic from the everninomicin family.Antimicrobial susceptibility patterns of enterococci causing infections in Europe. The European VRE Study Group.In vitro activities of SCH27899 alone and in combination with 17 other antimicrobial agents.In vivo activity and pharmacokinetics of ziracin (SCH27899), a new long-acting everninomicin antibiotic, in a murine model of penicillin-susceptible or penicillin-resistant pneumococcal pneumonia.Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients.Vancomycin resistance: occurrence, mechanisms and strategies to combat it.A brief history of antibiotics and select advances in their synthesis.In vitro activities of the everninomicin SCH 27899 and other newer antimicrobial agents against Borrelia burgdorferi.Evernimicin (SCH27899) inhibits both translation and 50S ribosomal subunit formation in Staphylococcus aureus cells.In vivo activities of evernimicin (SCH 27899) against vancomycin-susceptible and vancomycin-resistant enterococci in experimental endocarditis.Presence of variations in ribosomal protein L16 corresponding to susceptibility of enterococci to oligosaccharides (Avilamycin and evernimicin).In vivo activity of evernimicin (SCH 27899) against methicillin-resistant Staphylococcus aureus in experimental infective endocarditis.Incidence of high-level evernimicin resistance in Enterococcus faecium among food animals and humans.Cloning of an avilamycin biosynthetic gene cluster from Streptomyces viridochromogenes Tü57.Quinupristin/Dalfopristin therapy for infections due to vancomycin-resistant Enterococcus faecium.
P2860

Comparative in-vitro activity of SCH 27899, a novel everninomicin, and vancomycin.

Item
http://www.wikidata.org/entity/Q39425509
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Comparative in-vitro activity of SCH 27899, a novel everninomicin, and vancomycin.
@en
Comparative in-vitro activity of SCH 27899, a novel everninomicin, and vancomycin.
@nl
type
label
Comparative in-vitro activity of SCH 27899, a novel everninomicin, and vancomycin.
@en
Comparative in-vitro activity of SCH 27899, a novel everninomicin, and vancomycin.
@nl
prefLabel
Comparative in-vitro activity of SCH 27899, a novel everninomicin, and vancomycin.
@en
Comparative in-vitro activity of SCH 27899, a novel everninomicin, and vancomycin.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P356
P1433
P1476
Comparative in-vitro activity of SCH 27899, a novel everninomicin, and vancomycin.
@en
P2093
P304
P31
P356
P407
P433
P478
P577
P5875
P698